Bill
Corporate Income Tax - Addition Modification - Direct-to-Consumer...
HB484TaxationFiled
Providing an addition modification under the corporate income tax for the amount of certain direct-to-consumer advertising expenses for certain covered drugs paid or incurred during the taxable year that are deducted under the Internal Revenue Code; and applying the Act to all taxable years beginning after December 31, 2025.
Filed
In Committee
Passed Chamber
Final Approval